好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Computerized Assessment of Longitudinal Changes in Cognitive Function for Natalizumab-Treated Patients with Relapsing Remitting Multiple Sclerosis
MS and Related Diseases
(-)
072
Authors/Disclosures
Mark Gudesblatt, MD (South Shore Neurology Assoc. PC) The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
No disclosure on file
No disclosure on file
No disclosure on file
Ely S. Simon, MD (E.S. Neurological Consulting) No disclosure on file
Ilir Topalli No disclosure on file
No disclosure on file
Glen M. Doniger, PhD (NeuroTrax Israel Ltd.) No disclosure on file